Eli Lilly said it has begun selling single-dose vials of its popular weight-loss drug Zepbound in the U.S., aiming to meet intense demand for the obesity medication. Amandalina Letterio has the details and more in Health Matters for Aug. 27, 2024.
Health Matters
Health Matters: Eli Lilly launches single-dose vials weigh- loss drug to expand supply
More Videos
-
Health Matters: Germany to donate 100,000 mpox vaccines to combat outbreak
-
Excessive fluoride consumption linked to lower IQ in children: report
-
Health Matters: Assisted dying law faces court challenge
-
Health Matters: Kids can go to school with some symptoms of illness, health experts say
-
Health Matters: Mpox variant may come to Canada, experts say
You are viewing an Accelerated Mobile Webpage.
View Original Article